Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Parkinson's Disease

Free Subscription Articles published in J Neurochem Retrieve available abstracts of 64 articles: HTML format Text format

Single Articles

February 2010
1. RAQUEL ESTEVES A , Lu J, Rodova M, Onyango I, et al
   Mitochondrial Respiration and Respiration Associated Proteins in Cell Lines Created through Parkinson's Subject Mitochondrial Transfer.
   J Neurochem. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. OUATTARA B , Gasparini F, Morissette M, Gregoire L, et al
   Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
   J Neurochem. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
3. HSU CH , Chan D, Greggio E, Saha S, et al
   MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2.
   J Neurochem. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. LEE DW , Andersen JK
   Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?
   J Neurochem. 2010;112:332-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
5. LINDGREN HS , Andersson DR, Lagerkvist S, Nissbrandt H, et al
   L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
   J Neurochem. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. BAR-AM O , Weinreb O, Amit T, Youdim MB, et al
   The Neuroprotective Mechanism of 1-(R)-Aminoindan, the Major Metabolite of the Anti-Parkinsonian Drug Rasagiline.
   J Neurochem. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
7. CARTA AR , Kachroo A, Schintu N, Xu K, et al
   Inactivation of neuronal forebrain A(2A) receptors protects dopaminergic neurons in a mouse model of Parkinson's disease.
   J Neurochem. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
8. HATANO T , Kubo SI, Sato S, Hattori N, et al
   Pathogenesis of familial Parkinson's disease: New insights based on monogenic forms of Parkinson's disease.
   J Neurochem. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. SHIN JY , Park HJ, Ahn YH, Lee PH, et al
   Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: A direct comparison study.
   J Neurochem. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MULHERKAR SA , Sharma J, Jana NR
    The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein.
    J Neurochem. 2009;110:1955-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
11. BJORKLUND T , Hall H, Breysse N, Soneson C, et al
    Optimization of continuous in vivo DOPA production and studies of ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
12. HAJIEVA P , Mocko JB, Moosmann B, Behl C, et al
    Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
    J Neurochem. 2009;110:118-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. PARK JY , Kim KS, Lee SB, Ryu JS, et al
    On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft.
    J Neurochem. 2009;110:400-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
14. MARINOVA-MUTAFCHIEVA L , Sadeghian M, Broom L, Davis JB, et al
    Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. GILLARDON F
    Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration?
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. YANG L , Calingasan NY, Wille EJ, Cormier K, et al
    Combination therapy with Coenzyme Q(10) and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's Diseases.
    J Neurochem. 2009;109:1427-39.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. KIM S , Cho SH, Kim KY, Shin KY, et al
    Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
    J Neurochem. 2009;109:1483-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
18. CHAU K , Ching H, Schapira A, Cooper J, et al
    Relationship between Alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. SONG W , Patel A, Qureshi HY, Han D, et al
    The Parkinson Disease-associated A30P Mutation Stabilizes alpha-Synuclein against Proteasomal Degradation Triggered by Heme Oxygenase-1 Overexpression in Human Neuroblastoma Cells.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. KARUNAKARAN S , Ravindranath V
    Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. CHALIMONIUK M , Stolecka A, Zieminska E, Stepien A, et al
    Involvement of multiple protein kinases in cPLA(2) phosphorylation, AA release and cell death in in vivo and in vitro models of 1-methyl-4-phenylpyridinium-induced parkinsonism - the possible key role of PKG.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. SANCHEZ-IGLESIAS S , Mendez-Alvarez E, Iglesias-Gonzalez J, Munoz-Patino A, et al
    Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease.
    J Neurochem. 2009;109:879-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. CUOMO D , Martella G, Barabino E, Platania P, et al
    Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.
    J Neurochem. 2009;109:1096-105.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
24. LEE FK , Wong AK, Lee YW, Wan OW, et al
    The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
25. GLOECKNER CJ , Schumacher A, Boldt K, Ueffing M, et al
    The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
26. JOGLAR B , Rodriguez-Pallares J, Rodriguez-Perez AI, Rey P, et al
    The Inflammatory Response in the MPTP Model of Parkinson's Disease is Mediated by Brain Angiotensin: Relevance to Progression of the Disease.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. ANASTASIA A , Torre L, de Erausquin GA, Masco DH, et al
    Enriched Environment Protects the Nigrostriatal Dopaminergic System and Induces Astroglial Reaction in the 6-OHDA rat model of Parkinson's Disease.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. SHUKLA S , Chaturvedi R, Roy N, Agrawal A, et al
    Enhanced survival and function of neural stem cells derived dopaminergic neurons under influence of olfactory ensheathing cells in parkinsonian rats.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. LUNDBLAD M , af Bjerken S, Cenci MA, Pomerleau F, et al
    Chronic intermittent L-DOPA treatment induces changes in dopamine release.
    J Neurochem. 2009;108:998-1008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. LUO X , Zhang X, Shao W, Yin Y, et al
    Crucial roles of MZF-1 in the transcriptional regulation of apomorphine-induced modulation of FGF-2 expression in astrocytic cultures.
    J Neurochem. 2009;108:952-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
31. MARONGIU R , Spencer B, Crews L, Adame A, et al
    Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. SOSSI V , Dinelle K, Topping GJ, Holden JE, et al
    Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in-vivo imaging study.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. YASUDA T , Nihira T, Ren YR, Cao XQ, et al
    Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
    J Neurochem. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
34. DECUYPERE M , Lu Y, Miller DD, LeDoux MS, et al
    Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain.
    J Neurochem. 2008;107:1398-413.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. MABROUK OS , Volta M, Marti M, Morari M, et al
    Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonism.
    J Neurochem. 2008;107:1647-59.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
36. MARTI M , Trapella C, Morari M
    The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA.
    J Neurochem. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
37. KOBAYASHI H , Fukuhara K, Tada-Oikawa S, Yada Y, et al
    The mechanisms of oxidative DNA damage and apoptosis induced by norsalsolinol, an endogenous tetrahydroisoquinoline derivative associated with Parkinson's disease.
    J Neurochem. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. RODRIGUEZ-BLANCO J , Martin V, Herrera F, Garcia-Santos G, et al
    Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
    J Neurochem. 2008;107:127-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
39. GUILARTE TR , Burton NC, McGlothan JL, Verina T, et al
    Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): Implications to manganese-induced parkinsonism.
    J Neurochem. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. RODRIGUEZ-NAVARRO JA , Solano RM, Casarejos MJ, Gomez A, et al
    Gender differences and estrogen effects in parkin null mice.
    J Neurochem. 2008;106:2143-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. FLINN L , Bretaud S, Lo C, Ingham PW, et al
    Zebrafish as a new animal model for movement disorders.
    J Neurochem. 2008;106:1991-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
42. ALVAREZ-FISCHER D , Guerreiro S, Hunot S, Saurini F, et al
    Modelling Parkinson-like Neurodegeneration via Osmotic Minipump Delivery of MPTP and Probenecid.
    J Neurochem. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. FERRARIO JE , Rojas-Mayorquin AE, Saldana-Ortega M, Salum C, et al
    Pleiotrophin receptor RPTP-zeta/beta expression is upregulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats.
    J Neurochem. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. KIM C , Lee SJ
    Controlling the mass action of alpha-synuclein in Parkinson's disease.
    J Neurochem. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. VILA M , Ramonet D, Perier C
    Mitochondrial alterations in Parkinson's disease: new clues.
    J Neurochem. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
46. PARK HJ , Lee PH, Bang OY, Lee G, et al
    Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease.
    J Neurochem. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. CHOI DH , Kim EM, Son HJ, Joh TH, et al
    A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells.
    J Neurochem. 2008;106:405-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. DUKES AA , Van Laar VS, Cascio M, Hastings TG, et al
    Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine.
    J Neurochem. 2008;106:333-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. GERARD M , Debyser Z, Desender L, Baert J, et al
    FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T.
    J Neurochem. 2008;106:121-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
50. ZECCA L , Casella L, Albertini A, Bellei C, et al
    NEUROMELANIN CAN PROTECT AGAINST IRON MEDIATED OXIDATIVE DAMAGE IN SYSTEM MODELING IRON OVERLOAD OF BRAIN AGING AND PARKINSON'S DISEASE.
    J Neurochem. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. MOORE DJ , West AB, Dikeman DA, Dawson VL, et al
    Parkin mediates the degradation-independent ubiquitination of Hsp70.
    J Neurochem. 2008;105:1806-19.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. HASEGAWA T , Treis A, Patenge N, Fiesel FC, et al
    Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways.
    J Neurochem. 2008;105:1700-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
53. PLOWEY ED , Cherra SJ 3rd, Liu YJ, Chu CT, et al
    Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
    J Neurochem. 2008;105:1048-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. HERRERA AJ , de Pablos RM, Carreno-Muller E, Villaran RF, et al
    The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
    J Neurochem. 2008;105:750-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
55. FANTIN M , Auberson YP, Morari M
    Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.
    J Neurochem. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. CHATURVEDI RK , Flint Beal M
    PPAR: A therapeutic target in Parkinson's disease.
    J Neurochem. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. MILLS RD , Sim CH, Mok SS, Mulhern TD, et al
    Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).
    J Neurochem. 2008;105:18-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
58. MIYAZAKI S , Yanagida T, Nunome K, Ishikawa S, et al
    DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
    J Neurochem. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. LIU F , Nguyen JL, Hulleman JD, Li L, et al
    Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
    J Neurochem. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
60. THOMAS T , Timmer M, Cesnulevicius K, Hitti E, et al
    MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation - relevance in a mouse model of Parkinson's disease.
    J Neurochem. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. DIETZ GP , Stockhausen KV, Dietz B, Falkenburger BH, et al
    Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra.
    J Neurochem. 2008;104:757-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
62. BAR-ON P , Crews L, Koob AO, Mizuno H, et al
    Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.
    J Neurochem. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2007
63. NAGEL F , Falkenburger BH, Tonges L, Kowsky S, et al
    Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.
    J Neurochem. 2007;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. LAVOIE MJ , Cortese GP, Ostaszewski BL, Schlossmacher MG, et al
    The effects of oxidative stress on parkin and other E3 ligases.
    J Neurochem. 2007;103:2354-68.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: